Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies.
Soderquist CR, Freeman C, Lin WH, Leeman-Neill RJ, Gu Y, Carter MC, Stutzel KC, Sigcha E, Alobeid B, Fernandes H, Bhagat G, Mansukhani MM, Hsiao SJ.
Soderquist CR, et al.
J Mol Diagn. 2024 Jan;26(1):5-16. doi: 10.1016/j.jmoldx.2023.09.012. Epub 2023 Nov 20.
J Mol Diagn. 2024.
PMID: 37981089
Free article.